The virus is mutating very fast in Brazilian patients. Appearance of new serotypes could hinder development of vaccines and efficacy of diagnostic tests, according to a member of one of the leading group of scientists on Zika-related investigations.
The virus is mutating very fast in Brazilian patients. Appearance of new serotypes could hinder development of vaccines and efficacy of diagnostic tests, according to a member of one of the leading group of scientists on Zika-related investigations.